Rashmi Kanagal-Shamanna

138PUBLICATIONS
359CO-AUTHORS
Predictive and prognostic markersMedical devicesMedical infection agents (incl. prions)Regenerative medicine (incl. stem cells)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (138)

|Jul 10, 2026
Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms.

|Jun 29, 2026
Inflammatory immune modulators of AML lung infiltration and respiratory failure.

|Jun 04, 2026
Niche-level immune evasion in TP53 mutant AML residual disease revealed by spatial proteomics.

|Mar 28, 2026
Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes.

Alexandre Bazinet, Alex Bataller, Kelly Chien

|Mar 06, 2026
Performance of molecular scoring systems in hypomethylating agent-treated myelodysplastic neoplasms.

Kelly S Chien, Ziyi Li, Luca Lanino

|Feb 12, 2026
Ibrutinib with Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase II Study.

Mahesh Swaminathan, Alessandra Ferrajoli, Philip A Thompson

Pageof 23

Frequent Collaborators

56 joint publications

Guillermo Garcia-Manero

50 joint publications

Hagop M Kantarjian

48 joint publications

Courtney DiNardo

48 joint publications

Tapan M Kadia